Frailty: An Underappreciated Risk Factor for IBD Complications

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2024 Sep 5

PMID 39235680

Authors

Ananya Venkatesh

Ammu T Susheela

Bharati Kochar

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The prevalence of IBD in older adults is rapidly growing. Older adults with IBD are underrepresented in research and clinical trials and yet at great risk for adverse events. Therefore, understanding advanced aged associated constructs in older adults can be critical to improving the management of older adults with IBD.

Recent Findings: In this review, we present recent studies on frailty in IBD. We identify 4 major themes in the literature: studies that describe frailty in patients with IBD, studies that report on consequences of frailty, studies of frailty as a risk stratification modality, and studies of frailty as an exposure and outcome. In reviewing the literature, we discuss the heterogeneity that exists and outline future directions to ensure appropriate applications for frailty in the field of IBD.

References

Coward S, Benchimol E, Bernstein C, Avina-Zubieta A, Bitton A, Carroll M . Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis. Am J Gastroenterol. 2024; 119(8):1563-1570. PMC: 11288393. DOI: 10.14309/ajg.0000000000002687. View

Kochar B, Kalasapudi L, Ufere N, Nipp R, Ananthakrishnan A, Ritchie C . Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021; 27(9):1541-1543. DOI: 10.1093/ibd/izab052. View

Vieujean S, Caron B, Jairath V, Benetos A, Danese S, Louis E . Is it time to include older adults in inflammatory bowel disease trials? A call for action. Lancet Healthy Longev. 2022; 3(5):e356-e366. DOI: 10.1016/S2666-7568(22)00060-5. View

Kochar B, Long M, Galanko J, Raffals L, Ananthakrishnan A, Sandler R . Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset. Inflamm Bowel Dis. 2017; 23(7):1187-1194. PMC: 5469700. DOI: 10.1097/MIB.0000000000001115. View

Ananthakrishnan A, McGinley E, Binion D . Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2008; 15(2):182-9. DOI: 10.1002/ibd.20628. View

Norgard B, Zegers F, Knudsen T, Kjeldsen J, Lund K, Brodersen J . Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study. Aliment Pharmacol Ther. 2023; 58(1):48-59. DOI: 10.1111/apt.17520. View

Chan W, Kariyawasam V, Kim S, Pudipeddi A, Paramsothy S, Shim H . Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey. Eur J Gastroenterol Hepatol. 2020; 32(8):976-983. DOI: 10.1097/MEG.0000000000001768. View

Geisz M, Ha C, Kappelman M, Martin C, Chen W, Anton K . Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016; 22(6):1435-41. PMC: 4868778. DOI: 10.1097/MIB.0000000000000747. View

Juneja M, Baidoo L, Schwartz M, Barrie 3rd A, Regueiro M, Dunn M . Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012; 57(9):2408-15. DOI: 10.1007/s10620-012-2083-x. View

10.

Singh S, Iversen A, Allin K, Jess T . Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases. JAMA Netw Open. 2022; 5(9):e2234200. PMC: 9526086. DOI: 10.1001/jamanetworkopen.2022.34200. View

11.

Bewtra M, Newcomb C, Wu Q, Chen L, Xie F, Roy J . Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med. 2015; 163(4):262-70. PMC: 4925099. DOI: 10.7326/M14-0960. View

12.

Overcash J, Ford N, Kress E, Ubbing C, Williams N . Comprehensive Geriatric Assessment as a Versatile Tool to Enhance the Care of the Older Person Diagnosed with Cancer. Geriatrics (Basel). 2019; 4(2). PMC: 6630523. DOI: 10.3390/geriatrics4020039. View

13.

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

14.

Mitnitski A, Mogilner A, Rockwood K . Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2003; 1:323-36. PMC: 6084020. DOI: 10.1100/tsw.2001.58. View

15.

Orkaby A . Moving beyond chronological age: frailty as an important risk factor for cardiovascular disease. Eur Heart J. 2021; 42(37):3866-3868. DOI: 10.1093/eurheartj/ehab481. View

16.

Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

17.

Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K . Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013; 123(3):958-65. PMC: 3582124. DOI: 10.1172/JCI64096. View

18.

Haran J, McCormick B . Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease. Gastroenterology. 2020; 160(2):507-523. PMC: 7856216. DOI: 10.1053/j.gastro.2020.09.060. View

19.

Kochar B, Cai W, Cagan A, Ananthakrishnan A . Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020; 52(2):311-318. DOI: 10.1111/apt.15821. View

20.

Kochar B, Jylhava J, Soderling J, Ritchie C, Ludvigsson J, Khalili H . Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2022; 20(10):2358-2365.e11. PMC: 9294971. DOI: 10.1016/j.cgh.2022.01.001. View